Global Ovarian Cancer Market 2014-2018 - WAFF-TV: News, Weather and Sports for Huntsville, AL

Global Ovarian Cancer Market 2014-2018

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact

SOURCE Research and Markets

DUBLIN, July 4, 2014 /PRNewswire/ -- Research and Markets ( has announced the addition of the "Global Ovarian Cancer Market 2014-2018" report to their offering.

Ovarian cancer is a condition where a malignancy forms in the ovarian tissue and is caused by uncontrollable cell growth. It is one of the major gynaecological cancers worldwide and a leading cause of death. Ovarian cancer is difficult to diagnose in the initial stages because the symptoms are similar to that of gastric disorders like bloating, abdominal discomfort, difficulty in eating in the early stage and nausea, vomiting, constipation and diarrhoea in the later stages.

It is often diagnosed in advanced stages when the metastasis has set in because the diagnostic techniques are not well-developed. Ovarian cancer can be treated by using chemotherapy, targeted therapy, and surgery. Although the market has a limited number of drugs for the treatment of ovarian cancer currently, a strong product pipeline is in development for the forecast period.

The analysts forecast the Global Ovarian Cancer market will grow at a CAGR of 13.85 percent over the period 2013-2018.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Rate of Incidence and Prevalence

08. Market Segmentation by Type of Therapy

09. Pipeline Portfolio

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series

Companies Mentioned:

  • Aetera Zenteris Inc.
  • Amgen Inc.
  • Aprea AB
  • Astra Zeneca plc
  • Bionumerik Pharmaceuticals Inc.
  • Boehringer Ingelheim GmbH
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffman-La Roche Ltd
  • Genentech Inc.
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals Inc.
  • MEI Pharmaceuticals Inc.
  • Nektar Therapeutics
  • NeoPharm Inc.
  • Novogen Inc.
  • Oasmia Pharmaceuticals AB
  • Synta Pharmaceuticals Corp.

For more information visit

Media Contact: Laura Wood, +353-1-481-1716,

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

1414 North Memorial Parkway
Huntsville, AL 35801

WAFF Is a Proud Member
of the Raycom Family of Stations

FCC Public File
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and WAFF. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.